OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer cell metabolism and antitumour immunity
Mara De Martino, Jeffrey C. Rathmell, Lorenzo Galluzzi, et al.
Nature reviews. Immunology (2024) Vol. 24, Iss. 9, pp. 654-669
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

The hallmarks of cancer immune evasion
Claudia Galassi, Timothy A. Chan, Ilio Vitale, et al.
Cancer Cell (2024) Vol. 42, Iss. 11, pp. 1825-1863
Closed Access | Times Cited: 49

Tumor-induced metabolic immunosuppression: Mechanisms and therapeutic targets
Jean‐Ehrland Ricci
Cell Reports (2025) Vol. 44, Iss. 1, pp. 115206-115206
Closed Access | Times Cited: 2

Epithelial cell diversity and immune remodeling in bladder cancer progression: insights from single-cell transcriptomics
Jianpeng Li, Yunzhong Jiang, Minghai Ma, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1

Monitoring cellular dynamics upon infection using a holotomography-based approach
Ilaria Nunzi, Gloria D’Achille, Nada Dhaouadi, et al.
Methods in cell biology (2025), pp. 109-118
Closed Access

Metabolites and metabolic pathway reactions links to sensitization of immunotherapy in pan-cancer
Shaobo Yu, Yuzhen Gao, Feng Zhao, et al.
Deleted Journal (2025) Vol. 33, Iss. 1, pp. 200933-200933
Open Access

Nucleotide-binding domain, leucine-rich repeat, and pyrin domain-containing protein 3 inflammasome: From action mechanism to therapeutic target in clinical trials
Chunye Zhang, Shuai Liu, Yuxiang Sui, et al.
World Journal of Gastrointestinal Oncology (2025) Vol. 17, Iss. 2
Closed Access

Mitochondrial succinate feeds T cell exhaustion in cancer
Lorenzo Galluzzi, Emma Guilbaud, Abhishek D. Garg
Cancer Cell (2025) Vol. 43, Iss. 2, pp. 168-170
Closed Access

Astragali Radix-Curcumae Rhizoma normalizes tumor blood vessels by HIF-1α to anti-tumor metastasis in colon cancer
Yan Liang, Tingting Su, Shijiao Zhu, et al.
Phytomedicine (2025) Vol. 140, pp. 156562-156562
Open Access

Nanoparticle-based Traditional Chinese Medicine for Immunotherapy in Gastrointestinal Tumors
Linjia Peng, Yan‐Feng Liang, Qiuli Zhang, et al.
Nano Biomedicine and Engineering (2025)
Open Access

Harnessing FLASH irradiation to improve immunotherapy of medulloblastoma
María Cecilia Lira, Claire Vanpouille‐Box, Mara De Martino
Trends in cancer (2025)
Closed Access

Multifunctional nanoparticle-mediated targeting of metabolic reprogramming and DNA damage response pathways to treat drug-resistant triple-negative breast cancer
Sifeng Zhu, Chao Sun, Zimin Cai, et al.
Journal of Controlled Release (2025) Vol. 381, pp. 113601-113601
Closed Access

Activation of pyroptosis and immunogenic cell death by targeted liposomal cisplatin for enhanced chemo-immunotherapy for osteosarcoma
Jingyou Bi, Yuchen Han, Xin-Li Han, et al.
Nano Today (2025) Vol. 62, pp. 102717-102717
Closed Access

CTHRC1: a key player in colorectal cancer progression and immune evasion
Qingjie Chen, Haohao Wang, Qinghua Liu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access

Type III interferon primes pDCs for TLR7 activation and antagonizes immune suppression mediated by TGF-β and PGE2
Candice Sakref, Alexis Saby, Céline Rodriguez, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access

Therapeutically targeting endometrial cancer in preclinical models by ICAM1 antibody-drug conjugates
Hanfei Xie, Lu Sun, Shili Yao, et al.
Gynecologic Oncology (2025) Vol. 196, pp. 16-27
Closed Access

Metabolic Reprogramming of Tumor Microenviroment by Engineered Bacteria
Heng Wang, Fang Xu, Chao Wang
Seminars in Cancer Biology (2025)
Closed Access

Page 1 - Next Page

Scroll to top